|
HY-103174-10mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103174-5mg
|
MedChemexpress LLC
|
MRS1334 [CAS 192053-05-7]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-10mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-100mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-25mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-5mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-50mg
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-103310-1mL
|
MedChemexpress LLC
|
MRS1845 [CAS 544478-19-5] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-145962A-10mg
|
MedChemexpress LLC
|
MRTX-EX185 (formic)
|
|
Cancer-Kinase/protease
|
|
|
HY-145962A-5mg
|
MedChemexpress LLC
|
MRTX-EX185 (formic)
|
|
Cancer-Kinase/protease
|
|
|
HY-132301-10mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-100mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-25mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-5mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-50mg
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7]
|
|
Cancer-programmed cell death
|
|
|
HY-132301-1mL
|
MedChemexpress LLC
|
MSC-4381 [CAS 2445185-57-7] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-114759-10mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-100mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-25mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-5mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-50mg
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0]
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-114759-1mL
|
MedChemexpress LLC
|
MS-PPOH [CAS 206052-02-0] (10mM in DMSO)
|
|
Metabolism-sugar/lipid metabolism
|
|
|
HY-140521-100mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140521-50mg
|
MedChemexpress LLC
|
N-(Acid-PEG2)-N-bis(PEG3-azide) [CAS 2320560-35-6]
|
|
Cancer-programmed cell death
|
|
|
HY-140091-100mg
|
MedChemexpress LLC
|
N-(Aminooxy-PEG2)-N-bis(PEG3-propargyl) [CAS 2112737-71-8]
|
|
Cancer-programmed cell death
|
|
